Kristin Anne Connarn

Kristin Anne Connarn


Email [email protected]​

Phone +1 617 371 1003

Fax +1 617 371 1037

Practice groupIntellectual Property, Media, and Technology

Kristin A. Connarn leverages her background in biotechnology and cancer research to effectively guide clients through strategic patent portfolio development and management. Her practice focuses on life sciences patent prosecution, portfolio development, and management in the biotechnology and pharmaceutical sectors.

Kristin's clients range from startups to international pharmaceutical companies, nonprofits, medical centers, and universities, as well as venture capital and private equity investors. She supports clients in strategic counseling, patent portfolio development and management, and patent prosecution. She also guides clients through transactions and agreements that involve intellectual property assets, including joint development agreements, sponsored research agreements, licenses, and complex commercial transactions.

Kristin has vast experience working with companies developing novel biologics in the cell and gene therapy spaces, including oncology, autoimmune, and inflammatory diseases. She assists clients in developing and executing IP protection strategies on therapeutic antibodies, recombinant proteins, targeted delivery of therapeutic including using antibodies and nanoparticles, and therapies including microbiome transplantations, CAR-T, CAR-NK, and TCR-T cells. Kristin also works with companies developing biologics to treat and prevent infections, including COVID-19.

Kristin's patent prosecution experience includes methods of treatment and diagnostics, dry powder inhalation therapies, food science, vaccines, and medical devices. She develops and delivers trainings for in-house legal and scientific teams regarding invention disclosures, patentability, and inventorship.

Kristin has industry experience as a researcher for the Cancer Bioscience and CNS groups at AstraZeneca R&D Boston, where she applied molecular and cell biology techniques to research cancer and Alzheimer's disease. She also researched gene activation with Transkaryotic Therapies.

Awards and recognitions

2018-2019, 2021

Patent Law
Best Lawyers in America


Patents: Prosecution
Legal 500 US


Ranked in U.S. (Massachusetts)
IAM Patent 1000


Boston Rising Star
The National Law Journal

Education and admissions


J.D., Suffolk University Law School, cum laude, 2005

B.S. Biotechnology, Worcester Polytechnic Institute, with high distinction, 1999

Bar admissions and qualifications


New Hampshire

Loading data